Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease

Neuroscience

Volumn 114, Issue 4, 2002, Pages 1103-1114

  Glockner F ^a   Meske, V ^a   Ohm, T G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

amyloid; Alzheimer's disease; Apolipoprotein E; Braak staging; Neurofibrillary tangles; Plasticity

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; DODECYL SULFATE SODIUM;

ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN; CONTROLLED STUDY; GENOTYPE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NERVE DEGENERATION; NEUROPATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONAL PLASTICITY; POSTMORTEM CHANGES;

EID: 0036837541     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00178-1     Document Type: Article

References (75)

1. Ackermann H. BIAS - A programme package for biometrical analysis of samples. Comp. Stat. 11:1991;223-224.
2. Aizawa Y., Fukatsu R., Takamaru Y., Tsuzuki K., Chiba H., Kobayashi K., Fujii N., Takahata N. Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease. Brain Res. 768:1997;208-214.
3. Arendt T., Schindler C., Brückner M.K., Eschrich K., Bigl V., Zedlick D., Markova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4 allele. J. Neurosci. 17:1997;516-529.
4. Barger S.W., Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 388:1997;878-881.
5. Beffert U., Cohn J.S., Petit Turcotte C., Tremblay M., Aumont N., Ramassamy C., Davignon J., Poirier J. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res. 843:1999;87-94.
6. Beffert U., Poirier J. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann. NY Acad. Sci. 777:1996;166-174.
7. Bellosta S., Nathan B.P., Orth M., Dong L.M., Mahley R.W., Pitas R.E. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270:1995;27063-27071.
8. Bertrand P., Poirier J., Oda T., Finch C.E., Pasinetti G.M. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Mol. Brain Res. 33:1995;174-178.
9. Beyreuther K., Masters C.L. Nomenclature of amyloid A4 proteins and their precursors in Alzheimers disease and Downs syndrome. Neurobiol. Aging. 11:1990;66-68.
10. Boyles J.K., Pitas R.E., Wilson E., Mahley R.W., Taylor J.M. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76:1985;1501-1513.
11. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. Berl. 82:1991;239-259.
12. Bullido M.J., Valdivieso F. Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease. Microsc. Res. Tech. 50:2000;261-267.
13. Cedazo-Minguez A., Hamker U., Veh R., Meske V., Albert F., Cowburn R.F., Ohm T.G. Regulation of apolipoprotein-E secretion in rat primary hippocampal astrocyte cultures. Neuroscience. 105:2001;651-661.
14. Cignarella A., Brennhausen B., von Eckardstein A., Assmann G., Cullen P. Differential effects of lovastatin on the trafficking of endogenous and lipoprotein-derived cholesterol in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 18:1998;1322-1329.
15. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E., Tanzi R.E., Gusella J.F., Small G.W., Roses A.D., Pericak Vance M.A., Haines J.L. Apolipoproein E. survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995;1323-1328.
16. Diedrich J.F., Minnigan H., Carp R.I., Whitaker J.N., Race R., Frey W., Haase A.T. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65:1991;4759-4768.
17. Fleming L.M., Weisgraber K.H., Strittmatter W.J., Troncoso J.C., Johnson G.V. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp. Neurol. 138:2001;252-260.
18. Gerdes L.U., Jeune B., Ranberg K.A., Nybo H., Vaupel J.W. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoproten E gene is a 'frailty gene' not a 'longevity gene'. Genet. Epidemiol. 19:2000;202-210.
19. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. USA. 85:1988;4051-4055.
20. Han S.H., Hulette C., Saunders A.M., EInstein G., Pericak-Vance M., Strittmatter W.J., Roses A.D., Schmechel D.E. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp. Neurol. 1994;13-26.
21. Harr S.D., Uint L., Hollister R., Hyman B.T., Mendez A.J. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J. Neurochem. 66:1996;2429-2435.
22. Hesse C., Bogdanovic N., Davidsson P., Blennow K. A quantitative and immunhistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 10:1999;452-459.
23. Huang D.Y., Weisgraber K.H., Goedert M., Saunders A.M., Roses A.D., Strittmatter W.J. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation. Neurosci. Lett. 192:1995;209-212.
24. Hyman B.T., van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1170.
25. Jian-Gang Z., Yong-Xing M., Chuan-Fu W., Pei-Fang L., Song-Bai Z., Nui-Fan G., Guo-Yin F., Lin H. Apolipoprotein E and longevity among Han Chinese population. Mech. Ageing Dev. 104:1998;159-167.
26. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
27. LaDu M.J., Falduto M.T., Manelli A.M., Reardon C.A., Getz G.S., Frail D.E. Isoform-specific binding of apolipoprotein E to beta-amyloid. J. Biol. Chem. 269:1994;23403-23406.
28. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., Van Eldik L.J. Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. J. Biol. Chem. 275:2000;33974-33980.
29. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
30. Laskowitz D.T., Horsburgh K., Roses A.D. Apolipoprotein E and the CNS response to injury. J. Cereb. Blood Flow Metab. 18:1998;465-471.
31. Mayeux R., Ottman R., Maestre G., Ngai C., Tang M.X., Ginsberg H., Chun M., Tycko B., Shelanski M. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease [see comments]. Neurology. 45:1995;555-557.
32. Meske V., Hamker U., Albert F., Ohm T.G. The effects of beta/A4-amyloid and its fragments on calcium homeostasis, glial fibrillary acidic protein and S100 beta staining, morphology and survival of cultured hippocampal astrocytes. Neuroscience. 85:1998;1151-1160.
33. Metzger R.E., LaDu M.J., Pan J.B., Getz G.S., Frail D.E., Falduto M.T. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;372-380.
34. Miehe U., Leranth C., Ohm T.G., Nitsch R. Long-lasting transneuronal dendritic changes of GABAergic neurons in the monkey dentate gyrus following entorhinal cortex lesion. Neurosci. Lett. 168:1994;115-118.
35. Mukaetova-Ladinska E.B., Garcia-Siera R., Hurt J., Gertz H.J., Xuereb J.H., Hills R., Brayne C., Huppert F.A., Paykel E.S., McGee M., Jakes R., Honer W.G., Harrington C.R., Wischik C.M. Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am. J. Pathol. 157:2000;623-636.
36. Muller W., Meske V., Berlin K., Scharnagl H., Marz W., Ohm T.G. Apolipoprotein E isoforms increase intracellular calcium differentially through a omega-agatoxin IVa-sensitive calcium-channel. Brain Pathol. 8:1998;641-653.
37. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein-E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
38. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
39. Nathan B.P., Chang K.C., Bellosta S., Brisch E., Ge N., Mahley R.W., Pitas R.E. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270:1995;19791-19799.
40. Nitsch R. Transneuronal changes in the lesioned entorhinal-hippocampal system. Hippocampus. 3:(Spec. No.):1993;247-256.
41. Ohm T.G., Muller H., Braak H., Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience. 64:1995;209-217.
42. Ohm T.G., Münch S., Schönheit B., Zarski R., Nitsch R. Transneuronally altered dendritic processing of tangle-free neurons in Alzheimer's disease. Acta Neuropathol. (Berlin). 103:2002;437-443.
43. Ohm T.G., Scharnagl H., Marz W., Bohl J. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions. Acta Neuropathol. (Berlin). 98:1999;273-280.
44. Pirttila T., Soininen H., Heinonen O., Lehtimaki T., Bogdanovic N., Paljarvi L., Kosunen O., Winblad B., Riekkinen P. Sr., Wisniewski H.M., Mehta P.D. Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls. Brain Res. 722:1996;71-77.
45. Pitas R.E., Boyles J.K., Lee S.H., Foss D., Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta. 917:1987;148-161.
46. Poirier J. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann. NY Acad. Sci. 924:2000;81-90.
47. Poirier J., Baccichet A., Dea D., Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience. 55:1993;81-90.
48. Ramassamy C., Averill D., Beffert U., Bastianetto S., Theroux L., Lussier-Cacan S., Cohn J.S., Christen Y., Davignon J., Quirion R., Poirier J. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic. Biol. Med. 27:1999;544-553.
49. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 11:1993;575-580.
50. Richey P.L., Siedlak S.L., Smith M.A., Perry G. Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis. Biochem. Biophys. Res. Commun. 208:1995;657-663.
51. Russo C., Angelini G., Dapino D., Piccini A., Piombo G., Schettini G., Chen S., Teller J.K., Zaccheo D., Gambetti P., Tabaton M. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 95:1998;15598-15602.
52. Samatovicz R.A. Genetics and brain injury: apolipoprotein E. J. Head Trauma Rehabil. 15:2000;869-874.
53. Saunders A.M. Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses. J. Neuropathol. Exp. Neurol. 59:2000;751-758.
54. Saunders A.M., Strittmatter W.J., Schmechel D., St.George-Hyslop P.H., Pericak Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele epsilon-4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;1467-1472.
55. Scharnagl H., Tisljar U., Winkler K., Hüttinger M., Nauck M.A., Gross W., Wieland H., Ohm T.G., März W. The A4 amyloid peptide enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor and heparan sulfate proteoglycans pathway. Lab. Invest. 79:1999;1271-1286.
56. Schwab C., Steele J.C., Akiyama H., McGeer P.L. Distinct distribution of apolipoprotein E and beta-amyloid immunoreactivity in the hippocampus of Parkinson dementia complex of Guam. Acta Neuropathol. (Berlin). 92:1996;378-385.
57. Shao Y., Gearing M., Mirra S.S. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study. J. Neuropathol. Exp. Neurol. 56:1997;376-381.
58. Strittmatter W.J., Saunders A.M., Goedert M., Weisgraber K.H., Dong L.M., Jakes R., Huang D.Y., Pericak Vance M., Schmechel D., Roses A.D. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;11183-11186.
59. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
60. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L.M., Salvesen G.S., Pericak Vance M., Schmechel D., Saunders A.M., Goldgaber D., Roses A.D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:1993;8098-8102.
61. Terrisse L., Poirier J., Bertrand P., Merched A., Visvikis S., Siest G., Milne R., Rassart E. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J. Neurochem. 71:1998;1643-1650.
62. Terrisse L., Seguin D., Bertrand P., Poirier J., Milne R., Rassart E. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Mol. Brain Res. 70:1999;26-35.
63. Tokuda T., Calero M., Matsubara E., Vidal R., Kumar A., Permanne B., Zlokovic B., Smith J.D., LaDu M.J., Rostagno A., Frangione B., Ghiso J. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem. J. 348:2000;359-365.
64. Tolar M., Keller J.N., Chan S., Mattson M.P., Marques M.A., Crutcher K.A. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J. Neurosci. 19:1999;7100-7110.
65. Tolar M., Marques M.A., Harmony J.A.K., Crutcher K.A. Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J. Neurosci. 17:1997;5678-5686.
66. Vassar R., Citron M. A beta-generating enzymes: recent advances in beta- and gamma-secretase research. Neuron. 27:2001;419-422.
67. Wang X.S., Gruenstein E. Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide. J. Cell Physiol. 173:1997;73-83.
68. Weaver C.L., Espinoza M., Kress V., Davies P. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging. 21:2000;719-727.
69. Weisgraber K.H. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res. 31:1990;1503-1511.
70. Weisgraber K.H., Roses A.D., Strittmatter W.J. The role of apolipoprotein E in the nervous system. Curr. Opin. Lipidol. 5:1994;110-116.
71. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
72. Xu P.T., Gilbert J.R., Qiu H.L., Ervin J., Rothrock Christian T.R., Hulette C., Schmechel D.E. Specific regional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol. 154:1999;601-611.
73. Yamada T., Kondo A., Takamatsu J.-I., Tateishi J., Goto I. Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. J. Neurol. Sci. 129:1995;56-61.
74. Yamaguchi H., Ishiguro K., Sugihara S., Nakazato Y., Kawarabayashi T., Sun X., Hirai S. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition. Acta Neuropathol. (Berlin). 88:1994;413-419.
75. Zarow C., Victoroff J. Increased apolipoprotein E mRNA in the hippocampus in Alzheimer's disease and in rats after entorhinal cortex lesioning. Exp. Neurol. 149:1997;79-86.